Results 51 to 60 of about 4,538,104 (325)

Linking calcium signaling and mitochondrial function in fungal drug resistance [PDF]

open access: yesProceedings of the National Academy of Sciences, 2020
The host range for Aspergillus fumigatus is wide, including mammals, aves, and insecta (stonebrood). This is linked to the significant adaptability of this important fungal pathogen. It is thermotolerant, able to grow up to 70 °C, and astonishingly also remains viable down to −20 °C (1).
Paul Bowyer   +2 more
openaire   +3 more sources

In vitro susceptibility of Cuban Aspergillus spp. strains of clinical and environmental origin

open access: yesBiomédica: revista del Instituto Nacional de Salud, 2017
Introduction: The behavior of antifungal susceptibility of Aspergillus spp. in Cuba remains unknown. The antifungals recommended to treat aspergillosis are amphotericin B, itraconazole, voriconazole and echinocandins. The influence of the environment may
Javier L. San Juan   +6 more
doaj   +1 more source

Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei [PDF]

open access: yes, 2016
Objectives The objective of this study was to identify the mechanisms of resistance to nifurtimox and fexinidazole in African trypanosomes. Methods Bloodstream-form Trypanosoma brucei were selected for resistance to nifurtimox and fexinidazole by ...
Kelner, Anna   +5 more
core   +1 more source

Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris

open access: yesNature Communications
The rise of drug-resistant fungal species, such as Candida auris, poses a serious threat to global health, with mortality rates exceeding 40% and resistance rates surpassing 90%.
Yuping Zhang   +16 more
semanticscholar   +1 more source

Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach

open access: yesVirulence, 2017
Increases in the incidence and mortality due to the major invasive fungal infections such as aspergillosis, candidiasis and cryptococcosis caused by the species of Aspergillus, Candida and Cryptococcus, are a growing threat to the immunosuppressed ...
Praveen R. Juvvadi   +3 more
semanticscholar   +1 more source

Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance [PDF]

open access: yes, 2004
Drug-resistant tuberculosis can be transmitted (primary) or develop during the course of treatment (secondary). We investigated risk factors for each type of resistance.
Glynn, JR   +5 more
core   +1 more source

Cryptococcus flips its lid – membrane phospholipid asymmetry modulates antifungal drug resistance and virulence

open access: yesMicrobial Cell, 2016
Human fungal infections are increasing in prevalence and acquisition of antifungal drug resistance, while our antifungal drug armamentarium remains very limited, constituting a significant public health problem. Despite the fact that prominent antifungal
Erika Shor   +3 more
doaj   +1 more source

Antifungal drug-resistance mechanisms in Candida biofilms

open access: yesCurrent Opinion in Microbiology, 2022
Infections caused by the Candida species of human fungal pathogens are a significant medical problem because they can disseminate to nearly every organ of the body. In addition, there are only a few classes of antifungal drugs available to treat patients
Jaspreet Kaur, Clarissa J. Nobile
semanticscholar   +1 more source

Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi [PDF]

open access: yes, 2008
Background: In contrast to the increasing numbers of agents for the treatment of invasive fungal infections, discoveries of new antifungal agents with therapeutic value in dermatomycoses are reported only rarely.
Borelli, Claudia   +10 more
core   +1 more source

Drug Resistance and Evolvability in an Emerging Human Fungal Pathogen

open access: yesmBio, 2022
Over the past decade, Candida auris has emerged as a highly transmissible human fungal pathogen. Because of its ability to transmit between patients in hospitals and its ability to rapidly develop drug resistance, C. auris presents unique challenges.
openaire   +3 more sources

Home - About - Disclaimer - Privacy